OptimizeRx Q3 2026 earnings call highlights margin expansion, programmatic focus
OptimizeRx held its Q3 2026 earnings call, with highlights pointing to margin expansion and a continued emphasis on programmatic advertising capabilities. No detailed figures or transcript excerpt were provided in the source item.